Lineage Cell Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | 84.0% | -966.5% | -694.4% |
| FY2015 | 84.3% | -935.3% | -667.9% |
| FY2016 | 94.0% | -995.6% | 566.8% |
| FY2017 | 95.1% | -1,125.0% | -577.7% |
| FY2018 | 93.9% | -837.9% | -922.0% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2014 | 84.0% | -966.5% | -694.4% |
| FY2015 | 84.3% | -935.3% | -667.9% |
| FY2016 | 94.0% | -995.6% | 566.8% |
| FY2017 | 95.1% | -1,125.0% | -577.7% |
| FY2018 | 93.9% | -837.9% | -922.0% |